The Future of Antisense Oligonucleotides in the Treatment of Respiratory Diseases

Antisense oligonucleotides (ASO) are short synthetic DNA molecules designed to inhibit translation of a targeted gene to protein via interaction with messenger RNA. More recently, small interfering (si)RNA have been developed as potent tools to specifically inhibit gene expression. ASO directed agai...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulanova, Marina, Schreiber, Alan D., Befus, A. Dean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2012
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100773/
https://www.ncbi.nlm.nih.gov/pubmed/16573347
http://dx.doi.org/10.2165/00063030-200620010-00001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100773/
https://www.ncbi.nlm.nih.gov/pubmed/16573347
http://dx.doi.org/10.2165/00063030-200620010-00001

Ejemplares similares